Importantly, the differential requirement for IL-1β in immune cell infiltration in the two GBM genotypes modeled in Chen, Giotti, et al. (8) indicates that intratumoral heterogeneity in patients must be considered. This evidence concerns the gene IL1B and glioblastoma.